| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.30M | - | |
| Other | 67.7K | $2.41M | - | |
| CFO | 40.3K | $1.44M | - | |
| Other | 34.6K | $1.23M | - | |
| Dir | 17.8K | $633.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $53.44 | $133,813.76 | -0.5% | |
| Mar 30, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $37.19 | $93,111.24 | -0.5% | |
| Feb 26, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $37.90 | $94,889.08 | -0.5% | |
| Jan 29, 2016 | Cantley Lewis Clayton Jr. | Director | Sell | 2,504 | $42.93 | $107,484.20 | -0.5% | |
| Dec 31, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $65.27 | $358,985.00 | -13.9% | |
| Dec 29, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 10,664 | $64.93 | $692,432.80 | -1.9% | |
| Dec 15, 2015 | Higgons John Duncan | Chief Operating Officer | Sell | 20,000 | $50.09 | $1,001,800.00 | -24.4% | |
| Nov 30, 2015 | Biller Scott | Chief Scientific Officer | Sale+OE | 5,500 | $65.99 | $362,945.00 | -13.9% | |
| Nov 17, 2015 | Cantley Lewis Clayton Jr. | Director | Sell | 9,408 | $59.83 | $562,871.14 | -1.7% | |
| Nov 16, 2015 | Higgons John Duncan | Chief Operating Officer | Sale+OE | 20,000 | $61.51 | $1,230,200.00 | -19.6% |